Delivery Order SPE2DB22D3401-SPE2DB24FT3HK
Award Date
6/6/24
Potential Completion Date
6/7/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) has an award value of $1,658.24. The contract is for the delivery of fluticasone propionate HFA 110 mcg inhalers, with an ultimate completion date of March 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,359,392 units of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The $1,937.74 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen, one of the largest pharmaceutical distribution companies...
This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,910.96 delivery order is for the supply of FLUTICASONE PROP HFA 220 MCG 12GM, a prescription medication. The contract has an ultimate completion date of July 16, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,830,242 units of the pharmaceutical product FLUTICASONE PROP HFA 110 MCG 12GM. The $1,356.97 firm fixed-price delivery order was awarded by the Defense Logistics Agency, a component of the Department of Defense. This contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, has a significant...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $1,442.25 by the Defense Logistics Agency (DLA) to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of a pharmaceutical product, Fluticasone Prop HFA 220 MCG 12GM, to the U.S. government. The contract is a Delivery Order with a Firm Fixed Price of $4,613.45 and an ultimate completion date of April 30, 2024. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD). Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract, valued at $1,035.80, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order with a completion date of May 29, 2024. The contract was awarded without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical products. The $1,879.11 firm fixed price delivery order was awarded on June 24, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 25, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds two indefinite delivery contracts...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $1,498.70, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a significant Indefinite...